C5aR-mediated myocardial ischemia/reperfusion injury
- 1 June 2007
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 357 (2) , 446-452
- https://doi.org/10.1016/j.bbrc.2007.03.152
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Protective effect of a human C5a receptor antagonist against hepatic ischaemia-reperfusion injury in ratsJournal of Hepatology, 2004
- Inhibition of complement factor C5 protects against renal ischemia-reperfusion injury: inhibition of late apoptosis and inflammation1Transplantation, 2003
- Identification of a Potent and Orally Active Non-peptide C5a Receptor AntagonistPublished by Elsevier ,2002
- Effects of a new C5a receptor antagonist on C5a- and endotoxin- induced neutropenia in the ratBritish Journal of Pharmacology, 1999
- Anti-C5a monoclonal antibody reduces cardiopulmonary bypass and cardioplegia-induced coronary endothelial dysfunctionThe Journal of Thoracic and Cardiovascular Surgery, 1998
- Small Molecular Probes for G-Protein-Coupled C5a Receptors: Conformationally Constrained Antagonists Derived from the C Terminus of the Human Plasma Protein C5aJournal of Medicinal Chemistry, 1998
- Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement.The Journal of Experimental Medicine, 1996
- Mitogen-activated Protein Kinase Activation Requires Two Signal Inputs from the Human Anaphylatoxin C5a ReceptorPublished by Elsevier ,1995
- Complement fragment C3a stimulates Ca2+ influx in neutrophils via a pertussis‐toxin‐sensitive G proteinEuropean Journal of Biochemistry, 1993
- Reduction by Cobra Venom Factor of Myocardial Necrosis after Coronary Artery OcclusionJournal of Clinical Investigation, 1978